Food/Recall·openFDA/food

Coco G's Snack Foods, Inc. — Class I: Coco G's Courmet Flaming Cheddar Hots, Spicy Cheddar Cheese Popcorn. Packaged in the foll

HighPublished Oct 7, 2026· AI-analyzed Oct 13, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Coco G's Snack Foods, Inc. has initiated a Class I recall for its Gourmet Flaming Cheddar Hots, Spicy Cheddar Cheese Popcorn due to potential Salmonella contamination. The recall involves three specific plastic bag sizes (2.5 oz, 4.15 oz, and 5 oz) identified by UPC.

Who it affects

This recall affects Coco G's Snack Foods, Inc., its distributors, retail partners, and quality/regulatory departments responsible for snack food safety and pathogen monitoring.

Why it matters

A Class I designation indicates a situation where there is a reasonable probability that exposure to the product will cause serious adverse health consequences or death. For regulatory professionals, this necessitates immediate action to secure inventory and highlights potential vulnerabilities in pathogen environmental monitoring or ingredient sourcing for cheese-based snack coatings.

Practical takeaway

Immediately cease distribution of affected UPCs, initiate formal recall procedures for all identified bag sizes, and conduct a root cause analysis to identify the source of Salmonella contamination within the production facility or raw material supply chain.

FDA source material

Class I. Reason: Potential Salmonella contamination.. Product: Coco G's Courmet Flaming Cheddar Hots, Spicy Cheddar Cheese Popcorn. Packaged in the following sized plastic bags: 1. 2.5 oz (81g), UPC 6 94161-25911 9. 2. 4.15 oz (118g), UPC 6 94161-38911 3. 3. 5 oz (142g), UPC 6 94161-60005 8. 761 Commerce Dr. Unit F, Union Grove, WI 53182. Firm: Coco G's Snack Foods, Inc. (Union Grove WI United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.